[Evidence-based evaluation of recent clinical practice guidelines for the diagnosis and treatment of benign prostatic hyperplasia].

• DOI: 10.3760/cma.j.issn.0376-2491.2017.22.002
• Publication Date: 2017-06-13
• Authors: Xian‐Tao Zeng; Sheng Li; Kan Gong; Zhuifeng Guo; T Z Liu; Dalin He; Xinghuan Wang
• Keywords: Rigour; Guideline; Excellence; Nice; CLARITY; Scope (computer science)

Objective: To systematically evaluate the quality of clinical practice guidelines for diagnosis and treatment benign prostatic hyperplasia (BPH), to compare context recommendations in order provide references application. Methods: We searched databases such as National Guideline Clearinghouse (NGC), Guidelines International Network (GIN), Institute Health Clinical Excellence (NICE), Scottish Intercollegiate (SIGN) World Organization (WHO), PubMed, Embase, CNKI, VIP, WanFang Data, CBM, Medlive from their establishment until August 13, 2016, collect evidence-based and/or consensus on BPH. Method: Methodological included was assessed according AGREE Ⅱ instrument, differences similarities among were compared. Results: A total 15 included. According score scope purpose, stakeholder involvement, rigour formulate, clarity presentation, applicability, editorial independence 72%, 38%, 30%, 58%, 16%, 40%, respectively. The different basically similar, only with conflicts some areas. Conclusions: remains be unified, them can valuable implications development or improvement.目的： 循证评价全球良性前列腺增生症临床诊治实践指南的制定情况、主要内容和方法学质量。 方法： 检索国内外指南发布平台和主要数据库，搜集良性前列腺增生症诊治的指南或共识，使用AGREE Ⅱ工具评价方法学质量，分析比较各指南推荐内容的异同。 结果： 共纳入指南15部。AGREE Ⅱ评分结果显示范围和目的、参与人员、制定的严谨性、清晰性、适用性和编辑的独立性得分分别为72%、38%、30%、58%、16%和40%。各指南的推荐意见基本相同，但在某些领域存在争议。 结论： 纳入指南整体质量良莠不齐，内容能为研发与完善指南提供有价值的启示。.